BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10318864)

  • 1. CTLA-4 ligation suppresses CD28-induced NF-kappaB and AP-1 activity in mouse T cell blasts.
    Olsson C; Riesbeck K; Dohlsten M; Michaëlsson E
    J Biol Chem; 1999 May; 274(20):14400-5. PubMed ID: 10318864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.
    Pioli C; Gatta L; Frasca D; Doria G
    Eur J Immunol; 1999 Mar; 29(3):856-63. PubMed ID: 10092088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells.
    Fraser JH; Rincón M; McCoy KD; Le Gros G
    Eur J Immunol; 1999 Mar; 29(3):838-44. PubMed ID: 10092086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 engagement regulates NF-kappaB activation in vivo.
    Harlin H; Hwang KW; Palucki DA; Kim O; Thompson CB; Boothby M; Alegre ML
    Eur J Immunol; 2002 Aug; 32(8):2095-104. PubMed ID: 12209621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 ligation blocks CD28-dependent T cell activation.
    Walunas TL; Bakker CY; Bluestone JA
    J Exp Med; 1996 Jun; 183(6):2541-50. PubMed ID: 8676075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4-Mediated inhibition of early events of T cell proliferation.
    Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
    J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone enhances CTLA-4 expression during T cell activation.
    Xia M; Gasser J; Feige U
    Cell Mol Life Sci; 1999 Sep; 55(12):1649-56. PubMed ID: 10526580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
    Martin M; Schneider H; Azouz A; Rudd CE
    J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.
    LeBlanc R; Hideshima T; Catley LP; Shringarpure R; Burger R; Mitsiades N; Mitsiades C; Cheema P; Chauhan D; Richardson PG; Anderson KC; Munshi NC
    Blood; 2004 Mar; 103(5):1787-90. PubMed ID: 14512311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
    Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
    J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation.
    Bosticardo M; Ariotti S; Losana G; Bernabei P; Forni G; Novelli F
    Eur J Immunol; 2001 Sep; 31(9):2829-38. PubMed ID: 11536182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A negative role for phosphoinositide 3-kinase in T-cell antigen receptor function.
    Reif K; Lucas S; Cantrell D
    Curr Biol; 1997 May; 7(5):285-93. PubMed ID: 9115394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
    Chen W; Jin W; Wahl SM
    J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES.
    Hidi R; Riches V; Al-Ali M; Cruikshank WW; Center DM; Holgate ST; Djukanovic R
    J Immunol; 2000 Jan; 164(1):412-8. PubMed ID: 10605037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.